NEUROONE MEDICAL TECHNOLOGIES Corp
For the period ended Sep 30, 2025. Filed Dec 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 17, 2025
NMTC$0.89+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Changes in Stockholders’ Equity
| Common Stock · Additional Paid–In · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Equity | |
| Balance at September 30, 2023 | 23,928,945 | $23,929 | $68,911,778 | $(62,686,303) | $6,249,404 |
| Issuance of common stock in connection with 2024 Private Placement | 2,944,446 | 2,944 | 833,833 | — | 836,777 |
| Issuance of common stock in connection with at-the-market offering program | 3,748,913 | 3,749 | 5,030,157 | — | 5,033,906 |
| Issuance costs in connection with common stock issuances | — | — | (296,161) | — | (296,161) |
| Stock-based compensation | — | — | 1,344,476 | — | 1,344,476 |
| Issuance of common stock upon vesting of restricted stock units | 267,305 | 267 | (267) | — | — |
| Share repurchases for the payment of employee taxes | (73,110) | (73) | (81,330) | — | (81,403) |
| Issuance of warrants in connection with debt facility | — | — | 53,124 | — | 53,124 |
| Net loss | — | — | — | (12,318,110) | (12,318,110) |
| Balance at September 30, 2024 | 30,816,499 | 30,816 | 75,795,610 | (75,004,413) | 822,013 |
| Issuance of common stock attributed to non-private placement equity offering | 18,755,899 | 18,756 | 9,595,281 | — | 9,614,037 |
| Issuance costs related to equity offerings | — | — | (1,056,646) | — | (1,056,646) |
| Stock-based compensation | — | — | 1,264,608 | — | 1,264,608 |
| Issuance of common stock upon vesting of restricted stock units | 399,034 | 399 | (399) | — | — |
| Exercise of warrants | 150,000 | 150 | 158,351 | — | 158,501 |
| Share repurchases for the payment of employee taxes | (114,968) | (115) | (124,502) | — | (124,617) |
| Net loss | (3,605,374) | (3,605,374) | |||
| Balance at September 30, 2025 | 50,006,464 | $50,006 | $85,632,303 | $(78,609,787) | $7,072,522 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.